Innospec IOSP · NASDAQ
$97.99 +1.22% (+$1.18)
Summary
66 / 100 · Bulios Score
What speaks for it
- It has raised its dividend 11 years in a row and pays out only 36% of profit.
- It holds more cash than debt: $250.2M against $47.9M.
What to watch
- The share price is above the Bulios Fair Price.
- Revenue fell by 3.3% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 19.9 USD for 1 USD of yearly profit. Over the last five years it was 31.9 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 8.3% a year over 5 years. Over the last 3 years it fell by 3.3% a year. Earnings per share fell by 4.3% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 73 USD
- Research and development 2.8 USD
- Sales and administration 17 USD
- Taxes and other 1.5 USD
- Net profit 6.6 USD
Net profit, industry median (Chemicals - Specialty) 5.9 USD
Out of every 100 USD of revenue, 6.6 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Small, stretched- Yield
- 1.83%
- Paid out of profit
- 36%
- Raised in a row
- 11 years
You receive $1.79 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 4
- Hold 5
- Sell 0
Today's price within the analysts' price targets
The average target of $110 is 12% above today's price. 44% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Fuel Specialties 39%
- Performance Chemicals 38%
- Oilfield Services 22%
By region
- UNITED STATES 45%
- UNITED KINGDOM 37%
- Rest Of World 18%
Fuel Specialties brings in 39% of revenue. Performance Chemicals grew fastest, by 6.7% a year.
Segments in detail